CCL21 and Bartsocas-Papas syndrome 1: CCR7, the receptor for CCL21, was also up-regulated in the NGS dataset (log2 FC 0.66, n.s.), so it is possible that at least in some BPS patients, the relevant signalling cascade is activated, contributing to the activation of the ERK and JNK pathways.